| __timestamp | Dynavax Technologies Corporation | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 84580000 | 382096000000 |
| Thursday, January 1, 2015 | 86943000 | 345927000000 |
| Friday, January 1, 2016 | 84493000 | 312303000000 |
| Sunday, January 1, 2017 | 64988000 | 325441000000 |
| Monday, January 1, 2018 | 74951000 | 368298000000 |
| Tuesday, January 1, 2019 | 62331000 | 492381000000 |
| Wednesday, January 1, 2020 | 28607000 | 455833000000 |
| Friday, January 1, 2021 | 32228000 | 526087000000 |
| Saturday, January 1, 2022 | 46600000 | 633325000000 |
| Sunday, January 1, 2023 | 54886000 | 729924000000 |
| Monday, January 1, 2024 | 729924000000 |
Data in motion
In the ever-evolving pharmaceutical industry, research and development (R&D) spending is a key indicator of a company's commitment to innovation. This analysis compares the R&D investments of Takeda Pharmaceutical Company Limited and Dynavax Technologies Corporation from 2014 to 2023. Over this period, Takeda consistently outspent Dynavax, with its R&D expenses peaking at approximately 730 billion yen in 2023, a staggering 1,200% more than Dynavax's highest expenditure in 2015.
Takeda's R&D spending grew by 91% from 2014 to 2023, reflecting its strategic focus on innovation. In contrast, Dynavax's R&D expenses fluctuated, with a notable dip in 2020, before recovering by 2023. This disparity highlights Takeda's robust financial commitment to research, positioning it as a leader in pharmaceutical innovation. The data for 2024 is incomplete, suggesting ongoing developments in both companies' R&D strategies.
Analyzing R&D Budgets: Zoetis Inc. vs Takeda Pharmaceutical Company Limited
Who Prioritizes Innovation? R&D Spending Compared for GSK plc and Dynavax Technologies Corporation
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs United Therapeutics Corporation
R&D Insights: How Takeda Pharmaceutical Company Limited and Exelixis, Inc. Allocate Funds
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs Iovance Biotherapeutics, Inc.
Takeda Pharmaceutical Company Limited vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Takeda Pharmaceutical Company Limited vs Celldex Therapeutics, Inc.
Takeda Pharmaceutical Company Limited or Taro Pharmaceutical Industries Ltd.: Who Invests More in Innovation?
Research and Development Investment: Takeda Pharmaceutical Company Limited vs BioCryst Pharmaceuticals, Inc.
Research and Development Investment: Corcept Therapeutics Incorporated vs Dynavax Technologies Corporation
Rhythm Pharmaceuticals, Inc. or Dynavax Technologies Corporation: Who Invests More in Innovation?
Comparing Innovation Spending: Xenon Pharmaceuticals Inc. and Dynavax Technologies Corporation